Anti-WIF1 antibody [EPR9385]
| Name | Anti-WIF1 antibody [EPR9385] |
|---|---|
| Supplier | Abcam |
| Catalog | ab155101 |
| Prices | $395.00 |
| Sizes | 100 µl |
| Host | Rabbit |
| Clonality | Monoclonal |
| Isotype | IgG |
| Clone | EPR9385 |
| Applications | WB IP |
| Species Reactivities | Mouse, Rat, Human |
| Antigen | Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) corresponding to Human WIF1 |
| Blocking Peptide | WIF1 peptide |
| Description | Rabbit Monoclonal |
| Gene | WIF1 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
![All lanes : Anti-WIF1 antibody [EPR9385] (ab155101) at 1/1000 dilution (unpurified)Lane 1 : HT29 cell lysateLane 2 : HeLa cell lysateLane 3 : Human fetal lung tissue lysateLysates/proteins at 10 µg per lane.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_5/21313_WIF1-Primary-antibodies-ab155101-1.jpg)
All lanes : Anti-WIF1 antibody [EPR9385] (ab155101) at 1/1000 dilution (unpurified)Lane 1 : HT29 cell lysateLane 2 : HeLa cell lysateLane 3 : Human fetal lung tissue lysateLysates/proteins at 10 µg per lane.
![All lanes : Anti-WIF1 antibody [EPR9385] (ab155101) at 1/1000 dilution (unpurified)Lane 1 : pmHep3B whole cell lysateLane 2 : pmHep3B whole cell lysateLane 3 : Hep3B whole cell lysateLane 4 : Hep3B whole cell lysateLysates/proteins at 30 µg per lane.SecondaryAlkaline Phosphatase conjugated goat anti-rabbit IgG polyclonal at 1/15000 dilutiondeveloped using the ECL techniquePerformed under non-reducing conditions.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_5/21314_ab155101-216582-ab155101wb.jpg)
All lanes : Anti-WIF1 antibody [EPR9385] (ab155101) at 1/1000 dilution (unpurified)Lane 1 : pmHep3B whole cell lysateLane 2 : pmHep3B whole cell lysateLane 3 : Hep3B whole cell lysateLane 4 : Hep3B whole cell lysateLysates/proteins at 30 µg per lane.SecondaryAlkaline Phosphatase conjugated goat anti-rabbit IgG polyclonal at 1/15000 dilutiondeveloped using the ECL techniquePerformed under non-reducing conditions.